blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1334088

EP1334088 - QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.10.2009
Database last updated on 03.10.2024
Most recent event   Tooltip16.10.2009Application deemed to be withdrawnpublished on 18.11.2009  [2009/47]
Applicant(s)For all designated states
GlaxoSmithKline S.p.A.
Via Alessandro Fleming, 2
37135 Verona / IT
For all designated states
Laboratoire Glaxosmithkline S.A.S.
100, route de Versailles
78163 Marly-le-Roi Cedex / FR
[2003/33]
Inventor(s)01 / FARINA, Carlo, Nikem Research S.r.l.
Via Zambeletti, 25
I-20021 Baranzate / IT
02 / GIARDINA, Giuseppe, Nikem Research S.r.l.
Via Zambletti, 25
I-20021 Baranzate / IT
03 / GRUGNI, Mario, Nikem Research S.r.l.
Via Zambelett, 25
I-20021 Baranzate / IT
04 / NADLER, Guy Margue. Marie Gerard, Glaxosmithkline
100 route de Versailles
F-78163 Marly-le-Roi Cedex / FR
 [2003/33]
Representative(s)Rutter, Keith
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2003/33]Rutter, Keith
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date01983584.212.11.2001
[2003/33]
WO2001EP13141
Priority number, dateGB2000002770113.11.2000         Original published format: GB 0027701
[2003/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0238548
Date:16.05.2002
Language:EN
[2002/20]
Type: A1 Application with search report 
No.:EP1334088
Date:13.08.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 16.05.2002 takes the place of the publication of the European patent application.
[2003/33]
Search report(s)International search report - published on:EP16.05.2002
ClassificationIPC:C07D215/52, A61K31/47, A61K31/4709, A61P11/06
[2003/33]
CPC:
C07D215/52 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P13/02 (EP);
A61P13/10 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P19/04 (EP); A61P25/02 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/08 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P25/32 (EP); A61P27/02 (EP);
A61P27/16 (EP); A61P29/00 (EP); A61P37/04 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/33]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:CHINOLIN-4-CARBOXAMIDDERIVATE ALS NK-3 UND NK-2 REZEPTOR ANTAGONISTEN[2003/33]
English:QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS[2003/33]
French:DERIVES DE QUINOLINE-4-CARBOXAMIDE UTILISES COMME ANTAGONISTES DE RECEPTEURS DE NK-3 ET NK-2[2003/33]
Entry into regional phase09.05.2003National basic fee paid 
09.05.2003Designation fee(s) paid 
09.05.2003Examination fee paid 
Examination procedure24.05.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.05.2003Examination requested  [2003/33]
17.12.2008Despatch of a communication from the examining division (Time limit: M04)
28.04.2009Application deemed to be withdrawn, date of legal effect  [2009/47]
12.06.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/47]
Fees paidRenewal fee
07.11.2003Renewal fee patent year 03
08.11.2004Renewal fee patent year 04
07.11.2005Renewal fee patent year 05
06.11.2006Renewal fee patent year 06
06.11.2007Renewal fee patent year 07
07.11.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]WO0031037  (SMITHKLINE BEECHAM SPA [IT], et al) [XD] 1-13 * examples 90,91; claim 13 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.